
    
      The purpose of the OTIS Autoimmune Diseases in Pregnancy Project, Cimzia Pregnancy Exposure
      Registry is to follow pregnant women with or without a Cimzia approved indication who have or
      have not been treated with Cimzia during pregnancy to evaluate the possible effect of these
      diseases, and or this medication on the pregnancy outcome including child development and
      growth up to five years of age.
    
  